Financials in USD. Standardized financial statements.
A compact view of how Ryman Healthcare Limited turns revenue into operating income and net income.
| Metric | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $824.34M | $713.80M | $650.53M | $560.11M | $503.76M | $452.41M | $422.11M | $381.80M | $342.10M | $288.73M |
| Revenue Growth? | +15.5% | +9.7% | +16.1% | +11.2% | +11.3% | +7.2% | +10.6% | +11.6% | +18.5% | 0.0% |
| Cost of Revenue? | $842.68M | $0 | $651.88M | $579.88M | $501.94M | $427.67M | $377.87M | $301.55M | $266.46M | $225.57M |
| Gross Profit? | -$18.34M | $713.80M | -$1.35M | -$19.77M | $1.82M | $24.74M | $44.25M | $80.26M | $75.64M | $63.16M |
| Gross Margin? | -2.2% | +100.0% | -0.2% | -3.5% | +0.4% | +5.5% | +10.5% | +21.0% | +22.1% | +21.9% |
| Operating Expenses? | $0 | $832.05M | $720.14M | $215.55M | $710.19M | $369.38M | $115.82M | $267.58M | $329.36M | $310.03M |
| Operating Income? | -$18.34M | -$118.26M | -$69.61M | -$19.77M | $1.82M | $24.74M | $44.25M | $54.93M | $53.48M | $48.23M |
| EBITDA? | $25.59M | -$27.16M | -$50.73M | $457.98M | $788.24M | $461.86M | $218.83M | $75.46M | $72.75M | $63.16M |
| Income Before Tax | -$183.37M | -$215.39M | -$144.93M | $206.20M | $722.08M | $410.50M | $171.15M | $329.42M | $388.86M | $362.99M |
| Income Tax Expense | -$6.47M | $221.44M | -$149.70M | -$51.64M | $29.21M | -$12.56M | -$93.56M | $3.43M | $640,000 | $6.29M |
| Net Income? | -$176.89M | -$436.83M | $4.78M | $257.84M | $692.87M | $423.06M | $264.71M | $325.99M | $388.22M | $356.69M |
| EPS? | $-0.90 | $-3.05 | $0.03 | $2.50 | $6.55 | $4.00 | $2.50 | $3.25 | $3.90 | $3.55 |
| Diluted EPS? | $-0.90 | $-3.05 | $0.03 | $2.50 | $6.55 | $4.00 | $2.50 | $3.25 | $3.90 | $3.55 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality